JUSTINE HUANG: Open Payments
NPI 1609402148 · LONG BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$976 in 33 payments from 16 companies in 2025. Trend: 2023 $422 · 2024 $731 · 2025 $976
Food & beverage: $887Education: $89
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $244 |
| Astellas Pharma US Inc | 2 | $109 |
| Janssen Biotech, Inc. | 3 | $94 |
| Telix Pharmaceuticals | 3 | $78 |
| Boston Scientific Corporation | 2 | $73 |
| Dendreon Pharmaceuticals LLC | 2 | $58 |
| PROGENICS PHARMACEUTICALS, INC. | 2 | $52 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Endo USA, Inc. | 2 | $37 |
| Novartis Pharmaceuticals Corporation | 1 | $31 |
Products named: BOTOX, ERLEADA, ILLUCCIX, PROVENGE, PYLARIFY, GEMTESA, Xtandi, Solyx SIS System.
Industry payments across CA — which companies pay providers there.
